RU93005170A - NUCLEIC ACIDS, APPLICATION OF NUCLEIC ACIDS, DIAGNOSTIC KITS, VACCINES, CELLS, PROTEIN, APPLICATION OF PROTEIN, ANTIBODIES, APPLICATION OF ANTIBODIES - Google Patents

NUCLEIC ACIDS, APPLICATION OF NUCLEIC ACIDS, DIAGNOSTIC KITS, VACCINES, CELLS, PROTEIN, APPLICATION OF PROTEIN, ANTIBODIES, APPLICATION OF ANTIBODIES

Info

Publication number
RU93005170A
RU93005170A RU93005170/13A RU93005170A RU93005170A RU 93005170 A RU93005170 A RU 93005170A RU 93005170/13 A RU93005170/13 A RU 93005170/13A RU 93005170 A RU93005170 A RU 93005170A RU 93005170 A RU93005170 A RU 93005170A
Authority
RU
Russia
Prior art keywords
application
protein
antibodies
nucleic acids
vaccines
Prior art date
Application number
RU93005170/13A
Other languages
Russian (ru)
Other versions
RU2146292C1 (en
Inventor
Хубертус Мария Нотеборн Матеус
Фоппе Де Бур Гербен
Original Assignee
Аскюлап Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NL9002008A external-priority patent/NL9002008A/en
Application filed by Аскюлап Б.В. filed Critical Аскюлап Б.В.
Publication of RU93005170A publication Critical patent/RU93005170A/en
Application granted granted Critical
Publication of RU2146292C1 publication Critical patent/RU2146292C1/en

Links

Claims (1)

Рекомбинантная генетическая информация /ДНК или РНК/, включающая нуклеотидную последовательность Вируса Куриной Анемии /КАВ/, и использование ее для диагностик, вакцинации или продуцирования белка. Рекомбинантный КАВ белок и его использование для диагностик, вакцинации или продуцирования КАВ-специфичных антител. Использование таким образом полученных КАВ-специфичных антител.Recombinant genetic information / DNA or RNA /, including the nucleotide sequence of Chicken Anemia Virus / CAV /, and its use for diagnostics, vaccination or protein production. Recombinant CAV protein and its use for the diagnosis, vaccination or production of CAV-specific antibodies. The use of thus obtained CAV-specific antibodies.
RU93005170A 1990-09-12 1991-09-11 Dna sequence, hybridous sample, oligonucleotide (variants), vaccines, chicken anemia virus protein (variants), diagnostic kits and escherichia coli strain RU2146292C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL9002008 1990-09-12
NL9002008A NL9002008A (en) 1990-09-12 1990-09-12 RECOMBINANT DNA AND RNA AND PRODUCTS DERIVED THEREFROM.
PCT/NL1991/000165 WO1992004446A1 (en) 1990-09-12 1991-09-11 Cloning of chicken anaemia dna

Publications (2)

Publication Number Publication Date
RU93005170A true RU93005170A (en) 1997-02-10
RU2146292C1 RU2146292C1 (en) 2000-03-10

Family

ID=19857669

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93005170A RU2146292C1 (en) 1990-09-12 1991-09-11 Dna sequence, hybridous sample, oligonucleotide (variants), vaccines, chicken anemia virus protein (variants), diagnostic kits and escherichia coli strain

Country Status (21)

Country Link
US (6) US5491073A (en)
EP (2) EP0905246A1 (en)
JP (1) JP2846116B2 (en)
AT (1) ATE188739T1 (en)
AU (1) AU651999B2 (en)
CA (1) CA2091181C (en)
DE (1) DE69131903T2 (en)
DK (1) DK0548234T3 (en)
ES (1) ES2144399T3 (en)
GR (1) GR3033173T3 (en)
HR (1) HRP940668B1 (en)
HU (1) HU220102B (en)
IL (1) IL99435A (en)
MX (1) MX9101042A (en)
NL (1) NL9002008A (en)
RU (1) RU2146292C1 (en)
SI (1) SI9111508B (en)
UA (1) UA48936C2 (en)
WO (1) WO1992004446A1 (en)
YU (1) YU49095B (en)
ZA (1) ZA917065B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922600A (en) * 1990-09-12 1999-07-13 Leadd Bv Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor
US20020061296A1 (en) * 2000-09-08 2002-05-23 Noteborn Mathieu H.M. Delivery method for the tumor specific apoptosis inducing activity of apoptin
US20080234466A1 (en) * 1990-09-12 2008-09-25 Noteborn Mathieu H M Delivery method for the tumor-specific apoptosis-inducing activity of apoptin
NL9301272A (en) * 1993-07-20 1995-02-16 Aesculaap Bv Chicken Anemia Virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or coding sequences of that virus.
US20030138443A1 (en) * 1993-03-08 2003-07-24 Noteborn Mathews H.M. Cloning of chicken anemia virus DNA
ZA918426B (en) * 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
EP0878546A1 (en) * 1997-04-15 1998-11-18 Leadd B.V. A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin
US5789567A (en) * 1994-07-06 1998-08-04 Cornell Research Foundation, Inc. Chicken infectious anemia virus vaccine
GB9414888D0 (en) * 1994-07-23 1994-09-14 Univ Belfast Method and composition
NZ309172A (en) * 1995-06-07 1999-11-29 Leadd B Neutralizing conformational epitopes of chicken anemia virus
AU1075197A (en) * 1995-11-14 1997-06-05 Mark A. Goodwin Efficient method of detecting an infectious agent in blood
PL196605B1 (en) 1997-08-12 2008-01-31 Leadd Bv Determination of transformability under influence of some factor
WO1999045956A1 (en) * 1998-03-13 1999-09-16 University Of Georgia Research Foundation, Inc. Vaccines against circovirus infections
ATE347597T1 (en) * 1999-09-02 2006-12-15 Leadd Bv APOPTIN BINDING PROTEIN
JP2003516152A (en) * 1999-12-10 2003-05-13 レアト ベー．フェー． Apoptin-associated protein
US6593134B1 (en) 2000-03-10 2003-07-15 Cornell Research Foundation, Inc. Method of propagating chicken infectious anemia virus
DE60133495T2 (en) * 2000-07-10 2009-07-09 Uni-Charm Corp., Shikokuchuo cleaning Supplies
EP1199363A1 (en) * 2000-10-20 2002-04-24 Leadd B.V. Phosphorylation modifications of apoptin
US20050169939A1 (en) * 2001-09-05 2005-08-04 Leonard Joan D. Chicken anemia virus vaccine from cell line
US7566548B2 (en) * 2004-08-13 2009-07-28 University Of Massachusetts Methods for identifying therapeutic agents and for treating disease
CN102636646A (en) * 2012-05-15 2012-08-15 扬州大学 Test paper strip for rapidly detecting avian leukosis antigen and preparation method thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2042888B (en) 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS6034925B2 (en) 1979-07-31 1985-08-12 帝人株式会社 Long-acting nasal preparation and its manufacturing method
JPS6032714A (en) 1983-08-01 1985-02-19 Teijin Ltd Stabilized powdery pharmaceutical composition for application to nasal mucous membrane
DE3583799D1 (en) 1985-01-11 1991-09-19 Abbott Lab Ltd SOLID PREPARATION WITH SLOW RELEASE.
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5059587A (en) 1987-08-03 1991-10-22 Toyo Jozo Company, Ltd. Physiologically active peptide composition for nasal administration
GB8723846D0 (en) 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
US5079005A (en) 1988-06-17 1992-01-07 Gupta Kashmiri L Time release protein
EP0748631B1 (en) * 1988-09-13 2006-02-08 Mérial Viral vaccines
GB2237510B (en) 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
US5271961A (en) 1989-11-06 1993-12-21 Alkermes Controlled Therapeutics, Inc. Method for producing protein microspheres
ZA918426B (en) 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic

Similar Documents

Publication Publication Date Title
RU93005170A (en) NUCLEIC ACIDS, APPLICATION OF NUCLEIC ACIDS, DIAGNOSTIC KITS, VACCINES, CELLS, PROTEIN, APPLICATION OF PROTEIN, ANTIBODIES, APPLICATION OF ANTIBODIES
ATE329616T1 (en) VIRAL NUCLEOTIDE SEQUENCE VR-2332 AND METHOD OF USE
YU150891A (en) RECOMBINANT GENETIC INFORMATION
ATE366314T1 (en) INFECTIOUS RNA VIRUS CLONES, VACCINES AND DERIVED DIAGNOSTIC ASSAY
DE69534568D1 (en) Mammalian telomerase
ATE26127T1 (en) RECOMBINANT DNA, HOST ORGANISMS TRANSFORMED WITH IT AND POLYPEPTIDES PRODUCED BY THE HOST ORGANISMS; PROCESSES FOR THEIR MANUFACTURE; DETECTION METHODS USING THE POLYPEPTIDES; COMPOSITIONS AND AGENTS CONTAINING THE POLYPEPTIDES; DNA SEQUENCES.
FI912105A0 (en) NEUROTROFIN-3, EN NY NEUROTROFISK FACTOR HAENFOERANDE SIG TILL NERBTILLVAEXTFAKTORN OCH NEUROTROFISK FACTOR HAERLEDD FRAON HJAERNA.
ATE120490T1 (en) STRESS PROTEINS FROM MUSHROOMS.
CA2005291A1 (en) Feline infectious peritonitis virus diagnostic tools
WO1999047639A3 (en) Staphylococcus aureus genes and polypeptides
DE3752131D1 (en) VACCINE AND DIAGNOSTIC TEST FOR HAEMOPHILUS INFLUENZAE
WO1998011226A3 (en) Mammalian chemokines, related reagents
BR9105237A (en) PROTEINS, PEPTIDES, DNA SEQUENCES, DNA OR RNA HYBRIDIZATION EVIDENCE, ANTIBODY, TUBERCULOSIS IMMUNE DIAGNOSIS, MICROORGANISM, TUBERCULOSIS VACCINE, PROCESS FOR TUBERCULOSIS TUBERCULOSIS TUBERCULOSIS
BR9713450A (en) Mammalian chemokines
DE68923286T2 (en) Vaccines and test kits for Haemophilus Influenza.
DE60017229D1 (en) DNA encoding the structural protein-1 of infectious salmon anemia virus and its uses
ATE143056T1 (en) IDENTIFICATION OF NEW DRUGS AND REAGENTS
WO1990012488A3 (en) A clone of double-stranded rna virus applied to antibody production, study of retrovirus-like frameshifting and production of proteins in yeast
KR950000879A (en) Novel Human Immunodeficiency Virus-2 (HIV-2)
EP1291357A3 (en) Recombinant protein materials which bind with anti-hcmv antibodies
ATE62268T1 (en) PEPTIDES, PHARMACEUTICAL COMPOSITIONS, GENES, VECTORS, HOST ORGANISMS, METHODS FOR THEIR PRODUCTION AND DIAGNOSTIC REAGENTS.